Clinical Trials
6 trialsNCT02465060 2026-05-26
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT04851119 2026-05-05
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Phase 1/2 Recruiting
NCT03699995 2026-04-08
MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma
OHSU Knight Cancer Institute
Phase NA Terminated
NCT05269381 2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2 Recruiting
NCT02760225 2024-05-03
Pembrolizumab-PET Imaging
University Medical Center Groningen
Phase NA Completed
NCT01295931 2015-10-07
Nuclear and Near-Infrared (NIR) Imaging in Melanoma
M.D. Anderson Cancer Center
Phase 1 Completed